Matthias Loehr - Director at PharmaCyte Biotech, Inc.

Issuer-level insider activity

Role
Director
Issuer ticker
PMCB on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Matthias Loehr since 13 Sep 2025

Reported holdings for Matthias Loehr in PharmaCyte Biotech, Inc.

Form 4 holding Director

PharmaCyte Biotech, Inc.

Security class
Common Stock
Shares / value
3,004
Estimated value
Report date
31 Mar 2022
Price
Ownership
By BB Biomed Consulting GMBH

Transaction history for Matthias Loehr in PharmaCyte Biotech, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .